spacer
spacer
Go to PDB code: 
protein Protein-protein interface(s) links
Cytokine/cytokine receptor PDB-id
1ktz
Asymmetric unit
Main view
    Jmol     Help!  
Contents
Description
Header details
Header records
References
PROCHECK
Protein chains
82 a.a. *
106 a.a. *
Waters ×163

* Residue conservation analysis
Tools
Image Generation
AstexViewer™@PDBe
Run PROCHECK
Clefts Calculation
  
  Biological unit, dimer
- as defined in PDB file (see also PQS)
PDB id: 1ktz
Name: Cytokine/cytokine receptor
Title: Crystal structure of the human tgf-beta type ii receptor extracellular domain in complex with tgf-beta3

Structure:
Transforming growth factor beta 3. Chain: a. Synonym: tgf-beta3. Engineered: yes. Tgf-beta type ii receptor. Chain: b. Fragment: extracellular domain. Synonym: tbr-2. Engineered: yes

Source:
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562. Expression_system_taxid: 562

Biological unit:
Dimer (from PDB file)

UniProt:
Chain A: P10600 (TGFB3_HUMAN)
Pfam   ArchSchema ?
Seq:
Struc:
Seq: 412 a.a.
Struc: 82 a.a.

Chain B: P37173 (TGFR2_HUMAN)
Pfam   ArchSchema ?
Seq:
Struc:
Seq:
Struc:
Seq: 567 a.a.
Struc: 106 a.a.
Key:    PfamA domain
 Secondary structure  CATH domain

Enzyme class:
Chain B: E.C.2.7.11.30   [IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

Reaction:
ATP + [receptor-protein] = ADP + [receptor-protein] phosphate

Resolution:
2.15Å

R-factor:
0.201

R-free:
0.215

Authors:
P.J.Hart,S.Deep,A.B.Taylor,Z.Shu,C.S.Hinck,A.P.Hinck

Key ref:
P.J.Hart et al. (2002). Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.. Nat Struct Biol, 9, 203-208. [PubMed id: 11850637] [DOI: 10.1038/nsb766]

Date:
18-Jan-02

Release date:
27-Feb-02
Quick_links
RCSB
PDBe
SRS
MMDB
JenaLib
OCA
PDBWiki
Proteopedia
CATH
SCOP
FSSP
HSSP
PDBSWS
PQS
ProSAT
Whatcheck
EDS
Procheck
Go to PROCHECK summary
Clefts
Clefts
Surface
RasMol surface
spacer
spacer

 
    Key reference    
 
 
DOI no: 10.1038/nsb766 Nat Struct Biol 9:203-208 (2002)
PubMed id: 11850637  
 
 
Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.
P.J.Hart, S.Deep, A.B.Taylor, Z.Shu, C.S.Hinck, A.P.Hinck.
 
  ABSTRACT  
 
Transforming growth factor-beta (TGF-beta) is the prototype of a large family of structurally related cytokines that play key roles in maintaining cellular homeostasis by signaling through two classes of functionally distinct Ser/Thr kinase receptors, designated as type I and type II. TGF-beta initiates receptor assembly by binding with high affinity to the type II receptor. Here, we present the 2.15 A crystal structure of the extracellular ligand-binding domain of the human TGF-beta type II receptor (ecTbetaR2) in complex with human TGF-beta3. ecTbetaR2 interacts with homodimeric TGF-beta3 by binding identical finger segments at opposite ends of the growth factor. Relative to the canonical 'closed' conformation previously observed in ligand structures across the superfamily, ecTbetaR2-bound TGF-beta3 shows an altered arrangement of its monomeric subunits, designated the 'open' conformation. The mode of TGF-beta3 binding shown by ecTbetaR2 is compatible with both ligand conformations. This, in addition to the predicted mode for TGF-beta binding to the type I receptor ectodomain (ecTbetaR1), suggests an assembly mechanism in which ecTbetaR1 and ecTbetaR2 bind at adjacent positions on the ligand surface and directly contact each other via protein--protein interactions.
 
  Selected figure(s)  
 
Figure 1.
Figure 1. Structure of the (ecT R2)[2]−TGF- 3 complex. a, Side view of the complex, with two ecT R2 molecules (green) and the two TGF- 3 monomers (blue and red). The TGF- 3 interchain disulfide bond is shown in black. The major secondary structural elements, as determined by the DSSP algorithm^42, and chain termini are labeled. b, Stereo view of ecT R2 (green) superimposed with ecActR2 (pink). The four ecT R2 disulfide bonds structurally equivalent to those in ecActR2 — 28-61, 54-78, 98-113 and 115-120 — are shown in blue. The two disulfides present within ecT R2 loop 1 (L1), 31-48 and 38-44, but not in ecActR2 are shown in red. The one disulfide present within ecActR2, 66-85, but not ecT R2 is shown in black. Side chains of the three ecT R2 residues at the interface with TGF- 3, Leu 27, Ile 53 and Glu 119, are shown in black. 4 designates -strand 4 that binds in the cleft between the TGF- 3 fingertips. ecActR2 residues that comprise the putative interface with activin, Phe 42, Trp 60 and Phe 83, are shown in red. ecT R2 loop 4 (L4) packs against the surface of the central -sheet, decreasing the accessibility of ecT R2 residues structurally equivalent to ecActR2 Phe 42, Trp 60 and Phe 83. c, Structural differences between bound and free TGF- 3. ecT R2-bound (blue and red monomers) and free (magenta and tan monomers) TGF- 3 homodimer structures are depicted by the left and right images, respectively. Shown within a single monomer are the 'fingertips' and the BMP type IA and putative type II receptor binding epitopes, designated as the 'wrist' and 'knuckle', respectively. For clarity, the 'thumb' epitope is shown on the symmetry-related monomer. d, Comparison of the free and bound TGF- 3 homodimer structures, in which the structures have been aligned by maximizing the alignment between the blue monomer of the bound form and the magenta monomer of the free form (1.1 Å root mean square (r.m.s.) deviation). Relative to the second monomer of free TGF- 3 (tan), the second monomer of the ecT R2-bound form (red) is rotated 101° around the axis shown.
Figure 3.
Figure 3. Contacts at the (ecT R2)[2]−TGF- 3 interface. a, Stereo view of the ecT R2−TGF- 3 interface in which the backbone and side chains of ecT R2 and TGF- 3 are green and blue, respectively. Disulfide bonds are black. Amino acid side chains are labeled according to the their residue numbers. b, Stereo view of the hydrogen-bonded ion pair between ecT R2 Asp 32 and TGF- 3 Arg 94. ecT R2 backbone and side chains are depicted in green; TGF- 3, in blue; and the interfacial water molecules, by red spheres. The [A]-weighted^44 electron density, with coefficients 2mF[o] - DF[c], is contoured at 1.1 . c, The molecular interaction surfaces of ecT R2 (top) and TGF- 3 (bottom). The molecules are color coded according to the electrostatic potential and are contoured at 25 kT. The interaction surfaces are defined by pairs of charged amino acids that lie at the periphery of their binding sites: Glu 119 and Asp 32 in ecT R2, and Arg 25 and Arg 94 in TGF- 3. In the complex, ecT R2 Asp 32 pairs with TGF- 3 Arg 94, and ecT R2 Glu 119 pairs with TGF- 3 Arg 25, as indicated by the arrows.
 
  The above figures are reprinted by permission from Macmillan Publishers Ltd: Nat Struct Biol (2002, 9, 203-208) copyright 2002.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19229295 A.Kotzsch, J.Nickel, A.Seher, W.Sebald, and T.D.Müller (2009).
Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificity.
  EMBO J, 28, 937-947.
PDB code: 3evs
19549280 I.Tesseur, H.Zhang, W.Brecht, J.Corn, J.S.Gong, K.Yanagisawa, M.Michikawa, K.Weisgraber, Y.Huang, and T.Wyss-Coray (2009).
Bioactive TGF-beta can associate with lipoproteins and is enriched in those containing apolipoprotein E3.
  J Neurochem, 110, 1254-1262.  
19207470 I.Torregroza, T.Evans, and B.C.Das (2009).
A forward chemical screen using zebrafish embryos with novel 2-substituted 2H-chromene derivatives.
  Chem Biol Drug Des, 73, 339-345.  
19644449 J.N.Cash, C.A.Rejon, A.C.McPherron, D.J.Bernard, and T.B.Thompson (2009).
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding.
  EMBO J, 28, 2662-2676.
PDB code: 3hh2
19424823 K.P.Holbourn, B.Perbal, and K.Ravi Acharya (2009).
Proteins on the catwalk: modelling the structural domains of the CCN family of proteins.
  J Cell Commun Signal, 3, 25-41.  
18485004 A.Galat, G.Gross, P.Drevet, A.Sato, and A.Ménez (2008).
Conserved structural determinants in three-fingered protein domains.
  FEBS J, 275, 3207-3225.  
19073914 C.Grütter, T.Wilkinson, R.Turner, S.Podichetty, D.Finch, M.McCourt, S.Loning, L.Jermutus, and M.G.Grütter (2008).
A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions.
  Proc Natl Acad Sci U S A, 105, 20251-20256.
PDB codes: 3eo0 3eo1
18789696 K.P.Holbourn, K.R.Acharya, and B.Perbal (2008).
The CCN family of proteins: structure-function relationships.
  Trends Biochem Sci, 33, 461-473.  
18436584 Y.Glinka, and G.J.Prud'homme (2008).
Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity.
  J Leukoc Biol, 84, 302-310.  
18397882 Y.Makanji, K.L.Walton, M.C.Wilce, K.L.Chan, D.M.Robertson, and C.A.Harrison (2008).
Suppression of inhibin A biological activity by alterations in the binding site for betaglycan.
  J Biol Chem, 283, 16743-16751.  
17295905 D.Weber, A.Kotzsch, J.Nickel, S.Harth, A.Seher, U.Mueller, W.Sebald, and T.D.Mueller (2007).
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
  BMC Struct Biol, 7, 6.
PDB codes: 2h62 2h64
17158104 P.M.Smallwood, J.Williams, Q.Xu, D.J.Leahy, and J.Nathans (2007).
Mutational analysis of Norrin-Frizzled4 recognition.
  J Biol Chem, 282, 4057-4068.  
17146441 T.Shimanuki, T.Hara, T.Furuya, T.Imamura, and K.Miyazono (2007).
Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
  Oncogene, 26, 3311-3320.  
16482217 A.E.Harrington, S.A.Morris-Triggs, B.T.Ruotolo, C.V.Robinson, S.Ohnuma, and M.Hyvönen (2006).
Structural basis for the inhibition of activin signalling by follistatin.
  EMBO J, 25, 1035-1045.
PDB codes: 2arp 2arv
17130459 A.Wong, S.N.Albright, and M.F.Wolfner (2006).
Evidence for structural constraint on ovulin, a rapidly evolving Drosophila melanogaster seminal protein.
  Proc Natl Acad Sci U S A, 103, 18644-18649.  
16606344 C.Sieber, F.Plöger, R.Schwappacher, R.Bechtold, M.Hanke, S.Kawai, Y.Muraki, M.Katsuura, M.Kimura, M.M.Rechtman, Y.I.Henis, J.Pohl, and P.Knaus (2006).
Monomeric and dimeric GDF-5 show equal type I receptor binding and oligomerization capability and have the same biological activity.
  Biol Chem, 387, 451-460.  
16891311 G.Liu, W.Ding, J.Neiman, and K.M.Mulder (2006).
Requirement of Smad3 and CREB-1 in mediating transforming growth factor-beta (TGF beta) induction of TGF beta 3 secretion.
  J Biol Chem, 281, 29479-29490.  
16672363 G.P.Allendorph, W.W.Vale, and S.Choe (2006).
Structure of the ternary signaling complex of a TGF-beta superfamily member.
  Proc Natl Acad Sci U S A, 103, 7643-7648.
PDB code: 2goo
16829514 S.Gao, and A.Laughon (2006).
Decapentaplegic-responsive silencers contain overlapping mad-binding sites.
  J Biol Chem, 281, 25781-25790.  
16384533 A.J.Gore, D.P.Philips, W.L.Miller, and D.J.Bernard (2005).
Differential regulation of follicle stimulating hormone by activin A and TGFB1 in murine gonadotropes.
  Reprod Biol Endocrinol, 3, 73.  
15739231 F.S.Cheah, E.W.Jabs, and S.S.Chong (2005).
Genomic, cDNA, and embryonic expression analysis of zebrafish transforming growth factor beta 3 (tgfbeta3).
  Dev Dyn, 232, 1021-1030.  
16480449 G.Valdimarsdottir, and C.Mummery (2005).
Functions of the TGFbeta superfamily in human embryonic stem cells.
  APMIS, 113, 773-789.  
15948132 H.H.Keah, and M.T.Hearn (2005).
A molecular recognition paradigm: promiscuity associated with the ligand-receptor interactions of the activin members of the TGF-beta superfamily.
  J Mol Recognit, 18, 385-403.  
15861141 P.Llinas, M.H.Le Du, H.Gårdsvoll, K.Danø, M.Ploug, B.Gilquin, E.A.Stura, and A.Ménez (2005).
Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide.
  EMBO J, 24, 1655-1663.
PDB code: 1ywh
16186117 R.W.Cook, T.B.Thompson, S.P.Kurup, T.S.Jardetzky, and T.K.Woodruff (2005).
Structural basis for a functional antagonist in the transforming growth factor beta superfamily.
  J Biol Chem, 280, 40177-40186.  
16212511 X.H.Feng, and R.Derynck (2005).
Specificity and versatility in tgf-beta signaling through Smads.
  Annu Rev Cell Dev Biol, 21, 659-693.  
14996829 E.del Re, J.L.Babitt, A.Pirani, A.L.Schneyer, and H.Y.Lin (2004).
In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.
  J Biol Chem, 279, 22765-22772.  
15475360 E.del Re, Y.Sidis, D.A.Fabrizio, H.Y.Lin, and A.Schneyer (2004).
Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system.
  J Biol Chem, 279, 53126-53135.  
15044491 G.De Crescenzo, P.L.Pham, Y.Durocher, H.Chao, and M.D.O'Connor-McCourt (2004).
Enhancement of the antagonistic potency of transforming growth factor-beta receptor extracellular domains by coiled coil-induced homo- and heterodimerization.
  J Biol Chem, 279, 26013-26018.  
15064755 S.Keller, J.Nickel, J.L.Zhang, W.Sebald, and T.D.Mueller (2004).
Molecular recognition of BMP-2 and BMP receptor IA.
  Nat Struct Mol Biol, 11, 481-488.
PDB codes: 1reu 1rew
15044950 V.M.Leppänen, M.M.Bespalov, P.Runeberg-Roos, U.Puurand, A.Merits, M.Saarma, and A.Goldman (2004).
The structure of GFRalpha1 domain 3 reveals new insights into GDNF binding and RET activation.
  EMBO J, 23, 1452-1462.
PDB code: 1q8d
15449706 W.Sebald, J.Nickel, J.L.Zhang, and T.D.Mueller (2004).
Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction.
  Biol Chem, 385, 697-710.  
14633986 D.G.Winkler, M.K.Sutherland, J.C.Geoghegan, C.Yu, T.Hayes, J.E.Skonier, D.Shpektor, M.Jonas, B.R.Kovacevich, K.Staehling-Hampton, M.Appleby, M.E.Brunkow, and J.A.Latham (2003).
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.
  EMBO J, 22, 6267-6276.  
12824914 K.Miyazono, H.Suzuki, and T.Imamura (2003).
Regulation of TGF-beta signaling and its roles in progression of tumors.
  Cancer Sci, 94, 230-234.  
12660162 T.B.Thompson, T.K.Woodruff, and T.S.Jardetzky (2003).
Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions.
  EMBO J, 22, 1555-1566.
PDB codes: 1nys 1nyu
12154125 B.Y.Qin, S.S.Lam, J.J.Correia, and K.Lin (2002).
Smad3 allostery links TGF-beta receptor kinase activation to transcriptional control.
  Genes Dev, 16, 1950-1963.
PDB codes: 1mjs 1mk2
12221089 E.V.Bocharov, D.M.Korzhnev, M.J.Blommers, T.Arvinte, V.Y.Orekhov, M.Billeter, and A.S.Arseniev (2002).
Dynamics-modulated biological activity of transforming growth factor beta3.
  J Biol Chem, 277, 46273-46279.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.